Skip to main content

Cluster of Differentiation 71 (CD71)

  • Chapter
  • First Online:
Angiogenesis in Health, Disease and Malignancy
  • 875 Accesses

Abstract

Cluster of Differentiation 71 protein (CD71), also known as the Transferrin receptor protein 1 (TfR1) is a protein encoded by the TFRC gene located on chromosome 3q29. It is found as a cell surface membrane protein in humans and is essential for iron delivery to the cells. TfR1 expression is up-regulated or down-regulated in response to cell’s iron need. A regulatory protein that regulates the interaction between Transferrin and Transferrin receptor is known as HFE1 and its mutation is thought to increase the risk of Alzheimer Disease. TfR1 knockdown cells have been also found to enhance VEGF production and angiogenesis in vivo. CD71 is used as a marker in breast cancer and has also been linked to many other cancers such as lungs, pancreas, lymph nodes and colon. The gene is currently being explored for its diagnostic and therapeutic opportunities. Currently, CD71 is a new target for the potential treatment of human lymphoma & leukaemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aisen P (2004) Transferrin receptor 1. Int J Biochem Cell Biol 36(11):2137–2143. doi:10.1016/j.biocel.2004.02.007

    Article  CAS  PubMed  Google Scholar 

  • Benarroch EE (2009) Brain iron homeostasis and neurodegenerative disease. Neurology 72(16):1436–1440. doi:10.1212/WNL.0b013e3181a26b30

    Article  PubMed  Google Scholar 

  • Blanchard J, Li X, Braun M, Milewski S, Cicalese L, Benedetti E, Rastellini C (2000) Administration of anti-Cd71 mab prolongs survival of heterotopic heart and skin graft.: Abstract# 321 Poster Board #-Session: P168-I. Transplantation 69(8):S197

    Article  Google Scholar 

  • Borie C, Gasparini F, Verpillat P, Bonnet AM, Agid Y, Hetet G, . . . Grandchamp B (2002) Association study between iron-related genes polymorphisms and Parkinson’s disease. J Neurol 249(7):801–804. doi:10.1007/s00415-002-0704-6

    Google Scholar 

  • Dongiovanni P, Valenti L, Ludovica Fracanzani A, Gatti S, Cairo G, Fargion S (2008) Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver. Am J Pathol 172(3):738–747. doi:10.2353/ajpath.2008.070097

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Eckard J, Dai J, Wu J, Jian J, Yang Q, Chen H, … Huang X (2010) Effects of cellular iron deficiency on the formation of vascular endothelial growth factor and angiogenesis. Iron deficiency and angiogenesis. Cancer Cell Int 10:28. doi:10.1186/1475-2867-10-28

    Google Scholar 

  • Habashy HO, Powe DG, Staka CM, Rakha EA, Ball G, Green AR, … Gee JM (2010) Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Res Treat 119(2):283–293. doi:10.1007/s10549-009-0345-x

    Google Scholar 

  • Jiang XP, Elliott RL, Head JF (2010) Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas. Anticancer Res 30(3):759–765

    CAS  PubMed  Google Scholar 

  • Liu Q, Wang M, Hu Y, Xing H, Chen X, Zhang Y, Zhu P (2014) Significance of CD71 expression by flow cytometry in diagnosis of acute leukemia. Leuk Lymphoma 55(4):892–898. doi:10.3109/10428194.2013.819100

    Article  CAS  PubMed  Google Scholar 

  • Oudemans PB, Brutel de la Riviere G, Hart GA, van Heerde P, Scholte G, Vroom TM (1986) Determination of transferrin receptors on frozen sections of malignant B-cell lymphomas by immunofluorescence with a monoclonal antibody. Cancer 58(6):1252–1259

    Article  CAS  PubMed  Google Scholar 

  • Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2(12):751–760. doi:10.1038/nnano.2007.387

    Article  CAS  PubMed  Google Scholar 

  • Speeckaert MM, Speeckaert R, Delanghe JR (2010) Biological and clinical aspects of soluble transferrin receptor. Crit Rev Clin Lab Sci 47(5–6):213–228. doi:10.3109/10408363.2010.550461

    Article  CAS  PubMed  Google Scholar 

  • Testa U, Kuhn L, Petrini M, Quaranta MT, Pelosi E, Peschle C (1991) Differential regulation of iron regulatory element-binding protein(s) in cell extracts of activated lymphocytes versus monocytes-macrophages. J Biol Chem 266(21):13925–13930

    CAS  PubMed  Google Scholar 

  • Testa U, Pelosi E, Peschle C (1993) The transferrin receptor. Crit Rev Oncog 4(3):241–276

    CAS  PubMed  Google Scholar 

  • Yefimova MG, Jeanny JC, Keller N, Sergeant C, Guillonneau X, Beaumont C, Courtois Y (2002) Impaired retinal iron homeostasis associated with defective phagocytosis in Royal College of Surgeons rats. Invest Ophthalmol Vis Sci 43(2):537–545

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Salajegheh, A. (2016). Cluster of Differentiation 71 (CD71). In: Angiogenesis in Health, Disease and Malignancy. Springer, Cham. https://doi.org/10.1007/978-3-319-28140-7_8

Download citation

Publish with us

Policies and ethics